CTA.PRA / EIDP, Inc. - Preferred Stock - Pengajuan SECLaporan Tahunan, Pernyataan Proksi

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2025

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2025 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 001-38710 Cort

MATTHEW J. PLATKIN ATTORNEY GENERAL OF NEW JERSEY R.J. Hughes Justice Complex 25 Market Street, P.O. Box 093 Trenton, New Jersey 08625-0093 Attorney for Plaintiffs By: Gwen Farley Deputy Attorney General Attorney ID No. 000081999 Ph. (609) 376-2740 G

njstatewidesettlementjco MATTHEW J. PLATKIN ATTORNEY GENERAL OF NEW JERSEY R.J. Hughes Justice Complex 25 Market Street, P.O. Box 093 Trenton, New Jersey 08625-0093 Attorney for Plaintiffs By: Gwen Farley Deputy Attorney General Attorney ID No. 000081999 Ph. (609) 376-2740 [email protected] UNITED STATES DISTRICT COURT DISTRICT OF NEW JERSEY NEW JERSEY DEPARTMENT OF ENVIRONMENTAL PROTECTIO

WITNESSETH

Exhibit 4.1 EIDP, INC. $500,000,000 5.125% Senior Notes due 2032 THIRD SUPPLEMENTAL INDENTURE Dated as of May 14, 2025 to INDENTURE Dated as of May 15, 2020 U.S. Bank Trust Company, National Association (as successor in interest to U.S. Bank National Association) Trustee Table of Contents Page ARTICLE I DEFINITIONS 2 Section 1.01 Definition of Terms 2 ARTICLE II GENERAL TERMS OF THE NOTES 5 Sectio

FORM 8-K Item 8.01 Other Events. Item 9.01 Financial Statements and Exhibits.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 14, 2025 EIDP, Inc. (Exact name of Registrant as Specified in Its Charter) Delaware 001-00815 51-0014090 (State or Other Jurisdiction of Incorporation) (Commission File Number) (I

EIDP, Inc. Debt Securities UNDERWRITING AGREEMENT

Exhibit 1.1 EIDP, Inc. Debt Securities UNDERWRITING AGREEMENT May 12, 2025 Ladies and Gentlemen: EIDP, Inc. (formerly known as E. I. du Pont de Nemours and Company), a Delaware corporation (the “Company”), proposes to issue and sell from time to time certain of its debt securities registered under the registration statement referred to in Section 1(a) (the “Securities”). The Securities will be iss

EIDP, Inc. $500,000,000 5.125% Senior Notes due 2032

Table of Contents Filed Pursuant to Rule 424(b)(2) File Number 333-287099-01 Prospectus Supplement (To Prospectus dated May 8, 2025) EIDP, Inc.

Calculation of Filing Fee Tables Form 424(b)(2) (Form Type) EIDP, INC. (Exact Name of Registrant as Specified in its Charter) Table 1: Newly Registered and Carry Forward Securities

Exhibit 107 Calculation of Filing Fee Tables Form 424(b)(2) (Form Type) EIDP, INC.

EIDP, Inc. $500,000,000 5.125% Senior Notes due 2032

Filed Pursuant to Rule 433 Registration No. 333-287099-01 Final Term Sheet May 12, 2025 EIDP, Inc. $500,000,000 5.125% Senior Notes due 2032 This final term sheet, dated May 12, 2025 (this “Final Term Sheet”), should be read together with the preliminary prospectus supplement, dated May 12, 2025 (the “Preliminary Prospectus Supplement”), of EIDP, Inc. (formerly known as E. I. du Pont de Nemours an

SUBJECT TO COMPLETION, DATED May 12, 2025

Table of Contents Filed Pursuant to Rule 424(b)(5) File Number 333-287099-01 The information in this preliminary prospectus supplement is not complete and may be changed.

As filed with the Securities and Exchange Commission on May 8, 2025

Table of Contents As filed with the Securities and Exchange Commission on May 8, 2025 Registration No.

as of 3/31/2025

Exhibit 25.1 securities and exchange commission Washington, D.C. 20549 FORM T-1 Statement of Eligibility Under The Trust Indenture Act of 1939 of a Corporation Designated to Act as Trustee ☐ Check if an Application to Determine Eligibility of a Trustee Pursuant to Section 305(b)(2) U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION (Exact name of Trustee as specified in its charter) 91-1821036 I.R.S. E

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2025

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2025 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 001-38710 Cor

Calculation of Filing Fee Tables Form S-3ASR (Form Type) Corteva, Inc. (Exact Name of Registrant as Specified in its Charter) EIDP, Inc. (Exact Name of Registrant as Specified in its Charter) Table 1—Newly Registered and Carry Forward Securities

Exhibit 107 Calculation of Filing Fee Tables Form S-3ASR (Form Type) Corteva, Inc.

SUBSIDIARIES OF THE REGISTRANT Set forth below are certain subsidiaries of Corteva, Inc. and EIDP, Inc. Name Organized Under Laws Of AG (Shanghai) Agriculture Technology Co., Ltd. Shanghai Agrigenetics, Inc. Delaware Agro Corteva Argentina S.R.L. Arg

Exhibit 21 SUBSIDIARIES OF THE REGISTRANT Set forth below are certain subsidiaries of Corteva, Inc.

Insider Trading Policy

Exhibit 19 Insider Trading Policy Policy Statement Purpose: One of the principal purposes of the federal securities laws is to prohibit “insider trading.

2024 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2024 OR ☐ TRANSITION REPOR

Table Of Contents 2024 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.

Current Report

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of Earliest Event Reported): February 4, 2025 EIDP, INC. (Exact Name of Registrant as Specified in Its Charter) Delaware 001-00815 51-0014090 (State or other jurisdiction of Incorporation) (Commission File Number

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2024

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 001-38710

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2024

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 001-38710 Cort

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2024

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 001-38710 Cor

AWARD TERMS OF TIME-VESTED RESTRICTED STOCK UNITS GRANTED UNDER THE

Exhibit 10.1 AWARD TERMS OF TIME-VESTED RESTRICTED STOCK UNITS GRANTED UNDER THE CORTEVA, INC. 2019 OMNIBUS INCENTIVE PLAN FOR GRANTEES LOCATED IN THE U.S. (OUTSIDE OF CALIFORNIA) Introduction/ Grant of Award You have been granted time-vested Restricted Stock Units under the Corteva, Inc. 2019 Omnibus Incentive Plan (“Plan”), subject to the following Award Terms. This grant is also subject to the

AWARD TERMS OF OPTIONS GRANTED UNDER THE

Exhibit 10.2 AWARD TERMS OF OPTIONS GRANTED UNDER THE CORTEVA, INC. 2019 OMNIBUS INCENTIVE PLAN FOR GRANTEES LOCATED IN THE U.S. (OUTSIDE OF CALIFORNIA) Introduction / Grant of Award You have been granted stock options under the Corteva, Inc. 2019 Omnibus Incentive Plan (“Plan”), subject to the following Award Terms. This grant is also subject to the terms of the Plan, which is hereby incorporated

AWARD TERMS OF PERFORMANCE-BASED RESTRICTED STOCK UNITS GRANTED UNDER THE

Exhibit 10.3 AWARD TERMS OF PERFORMANCE-BASED RESTRICTED STOCK UNITS GRANTED UNDER THE CORTEVA, INC. 2019 OMNIBUS INCENTIVE PLAN FOR GRANTEES LOCATED IN THE U.S. (OUTSIDE OF CALIFORNIA) Introduction You have been granted performance-based Restricted Stock Units (“Units”) under the Corteva, Inc. 2019 Omnibus Incentive Plan (“Plan”), subject to the following Award Terms. This grant is also subject t

2023 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2023 OR ☐ TRANSITION REPOR

Table Of Contents 2023 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.

CORTEVA, INC. CLAWBACK POLICY

Exhibit 97 CORTEVA, INC. CLAWBACK POLICY Administration. This Policy shall be administered and enforced by the People and Compensation Committee of the Company (the “Committee”) of Corteva, Inc. (the “Company”) and its decision as to all questions of interpretation and application of this Policy will be final, binding and conclusive on all persons. The Committee may delegate to a management commit

SUBSIDIARIES OF THE REGISTRANT Set forth below are certain subsidiaries of Corteva, Inc. Name Organized Under Laws Of AG (Shanghai) Agriculture Technology Co., Ltd. Shanghai Ag HoldCo Mexico S. de R.L. de C.V México AG MX 2, Inc. Delaware Agricor Ltd

Exhibit 21 SUBSIDIARIES OF THE REGISTRANT Set forth below are certain subsidiaries of Corteva, Inc.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2023

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number 001-38710 Corteva, Inc. (Exact Name of Regi

AFFF Settlement Funding

Exhibit 10.1 AFFF Settlement Funding This Supplemental Agreement to the MOU (as defined below) is entered into as of September 5, 2023 (this “Agreement”). Reference is made to the Memorandum of Understanding (the “MOU”), dated January 22, 2021, among The Chemours Company (“Chemours”), Corteva, Inc. (“Corteva”), E. I. du Pont de Nemours and Company (“EID”) and DuPont de Nemours, Inc. (f/k/a DowDuPo

AMENDMENT TO THE RETIREMENT SAVINGS RESTORATION PLAN Adopted: June 9, 2023

Exhibit 10.2 AMENDMENT TO THE RETIREMENT SAVINGS RESTORATION PLAN Adopted: June 9, 2023 WHEREAS, EIDP, Inc. (formerly known as E. I. du Pont de Nemours and Company) (the “Company”), a subsidiary of Corteva, Inc., has established the Retirement Savings Restoration Plan (the “Plan”), originally adopted effective January 1, 2007 and last amended effective January 1, 2021, for the benefit of its eligi

Management Deferred Compensation Plan (Amended and Restated Effective January 1, 2024) Adopted: June 9, 2023

Exhibit 10.1 Management Deferred Compensation Plan (Amended and Restated Effective January 1, 2024) Adopted: June 9, 2023 Article 1Purpose & Merger Involving The Dow Chemical Company. Section 1.01Purpose. Corteva Agriscience, LLC (the “Company”), a wholly-owned subsidiary of Corteva, Inc., desires to provide certain of its employees with an opportunity to accumulate additional retirement savings t

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2023

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number 001-38710 Corteva, Inc. (Exact Name of Registran

$1,200,000,000 EIDP, Inc. $600,000,000 4.500% Senior Notes due 2026 $600,000,000 4.800% Senior Notes due 2033

Table of Contents Filed Pursuant to Rule 424(b)(2) File Number 333-264764-01 Prospectus Supplement (To Prospectus filed May 6, 2022) $1,200,000,000 EIDP, Inc.

Calculation of Filing Fee Table FORM S-3 (Form Type) EIDP, Inc. (Exact Name of Registrant as Specified in its Charter) Table 1: Newly Registered Securities Security Type Security Class Title Fee Calculation or Carry Forward Rule Amount Registered Pro

EX-FILING FEES Exhibit 107 Calculation of Filing Fee Table FORM S-3 (Form Type) EIDP, Inc.

EIDP, Inc. $600,000,000 4.500% Senior Notes due 2026 $600,000,000 4.800% Senior Notes due 2033

FWP Filed Pursuant to Rule 433 Registration No. 333-264764-01 Final Term Sheet May 11, 2023 EIDP, Inc. $600,000,000 4.500% Senior Notes due 2026 $600,000,000 4.800% Senior Notes due 2033 This final term sheet, dated May 11, 2023 (this “Final Term Sheet”), should be read together with the preliminary prospectus supplement, dated May 11, 2023 (the “Preliminary Prospectus Supplement”), of EIDP, Inc.

SUBJECT TO COMPLETION, DATED MAY 11, 2023

Table of Contents Filed Pursuant to Rule 424(b)(5) File Number 333-264764-01 The information in this preliminary prospectus supplement is not complete and may be changed.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2023

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number 001-38710 Corteva, Inc. (Exact Name of Registra

SUBSIDIARIES OF THE REGISTRANT Set forth below are certain subsidiaries of Corteva, Inc.

Exhibit 21 SUBSIDIARIES OF THE REGISTRANT Set forth below are certain subsidiaries of Corteva, Inc.

AMENDED AND RESTATED CERTIFICATE OF INCORPORATION EIDP, INC.

Exhibit 3.3 AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF EIDP, INC. FIRST: The name of the corporation is EIDP, Inc. (the “Corporation”). SECOND: The address of the registered office of the Corporation in the State of Delaware is: Corporation Trust Center, 1209 Orange Street, Wilmington, DE 19801, County of New Castle. The name of its registered agent for service of process in the State of

2022 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2022 OR ☐ TRANSITION REPOR

Table Of Contents 2022 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.

SUBSIDIARIES OF THE REGISTRANT Set forth below are certain subsidiaries of Corteva, Inc. Name Organized Under Laws Of Ag HoldCo Mexico S. de R.L. de C.V México AG MX 2, Inc. Delaware Agar Cross Paraguaya S.A. Paraguay Agricor Ltd Zimbabwe Agrigenetic

Exhibit 21 SUBSIDIARIES OF THE REGISTRANT Set forth below are certain subsidiaries of Corteva, Inc.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2022

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2022 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number 001-38710 Corteva, Inc. (Exact Name of Regi

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2022

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number 001-38710 Corteva, Inc. (Exact Name of Registran

CRBU / Caribou Biosciences, Inc. / DUPONT E I DE NEMOURS & CO - SC 13G/A Passive Investment

SC 13G/A 1 d362685dsc13ga.htm SC 13G/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment NO. 1)* Caribou BioSciences, Inc. (Name of Issuer) Common Stock $0.0001 par value per share (Title of Class of Securities) 4203810 (CUSIP Number) (Date of Event Which Requires Filing of this Statement) Check the appropriate

Statement of Eligibility on Form T-1 of U.S. Bank National Association with respect to Exhibit 4.4.

Exhibit 25.2 SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM T-1 STATEMENT OF ELIGIBILITY UNDER THE TRUST INDENTURE ACT OF 1939 OF A CORPORATION DESIGNATED TO ACT AS TRUSTEE ? Check if an Application to Determine Eligibility of a Trustee Pursuant to Section 305(b)(2) U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION (Exact name of Trustee as specified in its charter) 91-1821036 I.R.S. E

As filed with the Securities and Exchange Commission on May 5, 2022

Table of Contents As filed with the Securities and Exchange Commission on May 5, 2022 Registration No.

Statement of Eligibility on Form T-1 of U.S. Bank National Association with respect to Exhibit 4.2.

Exhibit 25.1 SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM T-1 STATEMENT OF ELIGIBILITY UNDER THE TRUST INDENTURE ACT OF 1939 OF A CORPORATION DESIGNATED TO ACT AS TRUSTEE ? Check if an Application to Determine Eligibility of a Trustee Pursuant to Section 305(b)(2) U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION (Exact name of Trustee as specified in its charter) 91-1821036 I.R.S. E

Power of Attorney

Exhibit 24.1 POWER OF ATTORNEY KNOW ALL PERSONS BY THESE PRESENTS, that each person whose signature appears below hereby constitutes and appoints Charles V. Magro, David J. Anderson, and Cornel B. Fuerer, his or her true and lawful attorney-in-fact and agent, with full power of substitution and resubstitution, for him or her and in his or her name, place and stead, in any and all capacities, to si

Filing Fee Table

EX-FILING FEES 8 d332299dexfilingfees.htm EX-FILING FEES Exhibit 107.1 Calculation of Filing Fee Tables Form S-3 (Form Type) Corteva, Inc. (Exact Name of Registrant as Specified in Its Charter) E.I. Du Pont De Nemours and Company (Exact Name of Registrant as Specified in Its Charter) Table 1: Newly Registered and Carry Forward Securities Security Type Security Class Title Fee Calculation or Carry

AWARD TERMS OF TIME-VESTED RESTRICTED STOCK UNITS GRANTED UNDER THE

AWARD TERMS OF TIME-VESTED RESTRICTED STOCK UNITS GRANTED UNDER THE CORTEVA, INC. 2019 OMNIBUS INCENTIVE PLAN FOR GRANTEES LOCATED IN THE U.S. (OUTSIDE OF CALIFORNIA) Introduction/ Grant of Award You have been granted time-vested Restricted Stock Units under the Corteva, Inc. 2019 Omnibus Incentive Plan (“Plan”), subject to the following Award Terms. This grant is also subject to the terms of the

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2022

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number 001-38710 Corteva, Inc. (Exact Name of Registra

AWARD TERMS OF OPTIONS GRANTED UNDER THE

AWARD TERMS OF OPTIONS GRANTED UNDER THE CORTEVA, INC. 2019 OMNIBUS INCENTIVE PLAN FOR GRANTEES LOCATED IN THE U.S. (OUTSIDE OF CALIFORNIA) Introduction / Grant of Award You have been granted stock options under the Corteva, Inc. 2019 Omnibus Incentive Plan (“Plan”), subject to the following Award Terms. This grant is also subject to the terms of the Plan, which is hereby incorporated by reference

AWARD TERMS OF PERFORMANCE-BASED RESTRICTED STOCK UNITS GRANTED UNDER THE

AWARD TERMS OF PERFORMANCE-BASED RESTRICTED STOCK UNITS GRANTED UNDER THE CORTEVA, INC.

CRBU / Caribou Biosciences, Inc. / DUPONT E I DE NEMOURS & CO - SC 13G Passive Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* Caribou BioSciences, Inc. (Name of Issuer) Common Stock $0.0001 par value per share (Title of Class of Securities) 4203810 (CUSIP Number) (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to w

SUBSIDIARIES OF THE REGISTRANT Set forth below are certain subsidiaries of Corteva, Inc. Name Organized Under Laws Of Ag HoldCo Mexico S. de R.L. de C.V México AG MX 2, Inc. Delaware Agar Cross Paraguaya S.A. Paraguay Agricor Ltd Zimbabwe Agrigenetic

Exhibit 21 SUBSIDIARIES OF THE REGISTRANT Set forth below are certain subsidiaries of Corteva, Inc.

Form 10-K

2021 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2021 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number 001-38710 Corteva, Inc. (Exact Name of Registrant as S

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2021

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2021 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number 001-38710 Corteva, Inc. (Exact Name of Regi

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2021

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2021 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number 001-38710 Corteva, Inc. (Exact Name of Registran

MASTER FRAMEWORK AGREEMENT

MASTER FRAMEWORK AGREEMENT This MASTER FRAMEWORK AGREEMENT (this ?Framework Agreement?), is made and entered into as of February 9, 2021 (the ?Effective Date?), by and among: Co?peratieve Rabobank, U.

Quarterly Report - 10-Q

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2021 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number 001-38710 Corteva, Inc. (Exact Name of Registra

Master Repurchase

Master Repurchase Agreement September 1996 Version Dated as of February 9, 2021 Between: Co?peratieve Rabobank, U.

Annual Report - 10-K

2020 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2020 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number 001-38710 Corteva, Inc. (Exact Name of Registrant as S

SUBSIDIARIES OF THE REGISTRANT Set forth below are certain subsidiaries of Corteva, Inc. Name Organized Under Laws Of AG EMEA Holding 2 B.V. The Netherlands AG EMEA Holding 4 B.V. The Netherlands AG EMEA Holding B.V. The Netherlands Ag HoldCo Mexico

Exhibit 21 SUBSIDIARIES OF THE REGISTRANT Set forth below are certain subsidiaries of Corteva, Inc.

Quarterly Report - 10-Q

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2020 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number 001-38710 Corteva, Inc. (Exact Name of Regi

Quarterly Report - 10-Q

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2020 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number 001-38710 Corteva, Inc. (Exact Name of Registran

CALCULATION OF REGISTRATION FEE Title of each class of securities to be registered Amount to be registered Maximum offering price per unit Maximum aggregate offering price Amount of registration fee(1) 1.700% Senior Notes Due 2025 $500,000,000 99.910

424B2 Table of Contents Filed Pursuant to Rule 424(b)(2) Registration No. 333-231871-01 CALCULATION OF REGISTRATION FEE Title of each class of securities to be registered Amount to be registered Maximum offering price per unit Maximum aggregate offering price Amount of registration fee(1) 1.700% Senior Notes Due 2025 $500,000,000 99.910% $499,550,000 $64,841.59 2.300% Senior Notes Due 2030 $500,00

E.I. du Pont de Nemours and Company (d/b/a Corteva Agriscience) $500,000,000 1.700% Senior Notes due 2025 $500,000,000 2.300% Senior Notes due 2030

FWP 1 d876711dfwp.htm FWP Filed Pursuant to Rule 433 Registration No. 333-231871 Final Term Sheet May 13, 2020 E.I. du Pont de Nemours and Company (d/b/a Corteva Agriscience) $500,000,000 1.700% Senior Notes due 2025 $500,000,000 2.300% Senior Notes due 2030 This final term sheet, dated May 13, 2020 (this “Final Term Sheet”), should be read together with the preliminary prospectus supplement, date

SUBJECT TO COMPLETION, DATED MAY 12, 2020

424B5 Table of Contents Filed Pursuant to Rule 424(b)(5) Registration No. 333-231871-01 The information in this preliminary prospectus supplement is not complete and may be changed. This preliminary prospectus supplement and the accompanying prospectus are not an offer to sell the notes or a solicitation of an offer to buy the notes in any jurisdiction where the offer or sale is not permitted. SUB

AWARD TERMS OF TIME-VESTED RESTRICTED STOCK UNITS GRANTED UNDER THE CORTEVA, INC. 2019 OMNIBUS INCENTIVE PLAN FOR GRANTEES LOCATED IN THE U.S.

Exhibit 10.5 AWARD TERMS OF TIME-VESTED RESTRICTED STOCK UNITS GRANTED UNDER THE CORTEVA, INC. 2019 OMNIBUS INCENTIVE PLAN FOR GRANTEES LOCATED IN THE U.S. Introduction/Grant of Award You have been granted time-vested Restricted Stock Units under the Corteva, Inc. 2019 Omnibus Incentive Plan (“Plan”), subject to the following Award Terms. This grant is also subject to the terms of the Plan, which

Dated as of February 11, 2020 Between Coöperatieve Rabobank, U.A., New York Branch, MUFG Bank, Ltd., New York Branch, Standard Chartered Bank, acting through its New York branch, HSBC Bank USA, N.A. and PHI Financial Services, Inc.

EX-10.1 2 corteva-3312020xex101.htm EXHIBIT 10.1 Exhibit 10.1 Master Repurchase Agreement September 1996 Version Dated as of February 11, 2020 Between Coöperatieve Rabobank, U.A., New York Branch, MUFG Bank, Ltd., New York Branch, Standard Chartered Bank, acting through its New York branch, HSBC Bank USA, N.A. and PHI Financial Services, Inc. 1. Applicability From time to time the parties hereto m

AWARD TERMS OF OPTIONS GRANTED UNDER THE CORTEVA, INC. 2019 OMNIBUS INCENTIVE PLAN FOR GRANTEES LOCATED IN THE U.S. Introduction / Grant of Award You have been granted stock options under the Corteva, Inc. 2019 Omnibus Incentive Plan (“Plan”), subjec

Exhibit 10.3 AWARD TERMS OF OPTIONS GRANTED UNDER THE CORTEVA, INC. 2019 OMNIBUS INCENTIVE PLAN FOR GRANTEES LOCATED IN THE U.S. Introduction / Grant of Award You have been granted stock options under the Corteva, Inc. 2019 Omnibus Incentive Plan (“Plan”), subject to the following Award Terms. This grant is also subject to the terms of the Plan, which is hereby incorporated by reference. However,

Quarterly Report - 10-Q

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2020 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number 001-38710 Corteva, Inc. (Exact Name of Registra

MASTER FRAMEWORK AGREEMENT

EX-10.2 3 corteva-3312020xex102.htm EXHIBIT 10.2 Exhibit 10.2 MASTER FRAMEWORK AGREEMENT This MASTER FRAMEWORK AGREEMENT (this “Framework Agreement”), is made and entered into as of February 11, 2020 (the “Effective Date”), by and among: Coöperatieve Rabobank, U.A., New York Branch, a Dutch coöperatieve acting through its New York Branch (“Rabobank”), MUFG Bank, Ltd., New York Branch, a Japanese b

AWARD TERMS OF PERFORMANCE-BASED RESTRICTED STOCK UNITS GRANTED UNDER THE CORTEVA, INC. 2019 OMNIBUS INCENTIVE PLAN FOR GRANTEES LOCATED IN THE U.S.

Exhibit 10.4 AWARD TERMS OF PERFORMANCE-BASED RESTRICTED STOCK UNITS GRANTED UNDER THE CORTEVA, INC. 2019 OMNIBUS INCENTIVE PLAN FOR GRANTEES LOCATED IN THE U.S. Introduction You have been granted performance-based Restricted Stock Units (“Units”) under the Corteva, Inc. 2019 Omnibus Incentive Plan (“Plan”), subject to the following Award Terms. This grant is also subject to the terms of the Plan,

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 February 17, 2020 Date of Report (Date of earliest event reported) DuPont de Nemours, Inc. (Exact name of registrant as specified in its charter) Delaware 001-38196 81-1224539 (State or other jurisdiction of incorporation) (Commissio

Press Release dated February 18, 2020

EX-99.1 Exhibit 99.1 DuPont Announces Leadership Changes Ed Breen Returns to CEO Role, becoming Executive Chairman and Chief Executive Officer; Lori Koch Named Chief Financial Officer WILMINGTON, Del., Feb. 18, 2020 – DuPont [NYSE: DD] today announced that its Board of Directors has appointed current Executive Chairman Edward D. Breen to the additional role of Chief Executive Officer. Lori D. Koch

SUBSIDIARIES OF THE REGISTRANT Set forth below are certain subsidiaries of Corteva, Inc. Name Organized Under Laws Of 3319858 Nova Scotia Company Canada AG EMEA Cooperatief U.A. The Netherlands AG EMEA Holding 1 BV The Netherlands AG EMEA Holding 2 B

Exhibit 21 SUBSIDIARIES OF THE REGISTRANT Set forth below are certain subsidiaries of Corteva, Inc.

Statement of Eligibility on Form T-1 of U.S. Bank National Association with respect to Exhibit 4.4.

EX-25.2 Exhibit 25.2 SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM T-1 STATEMENT OF ELIGIBILITY UNDER THE TRUST INDENTURE ACT OF 1939 OF A CORPORATION DESIGNATED TO ACT AS TRUSTEE ☒ Check if an Application to Determine Eligibility of a Trustee Pursuant to Section 305(b)(2) U.S. BANK NATIONAL ASSOCIATION (Exact name of Trustee as specified in its charter) 31-0841368 I.R.S. Employer

Powers of Attorney.

EX-24.1 Exhibit 24.1 Certified Resolution Abigail Jarrell, Assistant Secretary of Corteva, Inc. (the “Corporation”), a corporation organized and existing under the laws of the State of Delaware, do hereby certify that the following resolutions was duly adopted by the Board of Directors of the Corporation and that such resolutions have not been amended, modified or rescinded and is in full force an

Statement of Eligibility on Form T-1 of U.S. Bank National Association with respect to Exhibit 4.2.

EX-25.1 10 d888077dex251.htm EX-25.1 Exhibit 25.1 SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM T-1 STATEMENT OF ELIGIBILITY UNDER THE TRUST INDENTURE ACT OF 1939 OF A CORPORATION DESIGNATED TO ACT AS TRUSTEE ☒ Check if an Application to Determine Eligibility of a Trustee Pursuant to Section 305(b)(2) U.S. BANK NATIONAL ASSOCIATION (Exact name of Trustee as specified in its charte

CTVA / Corteva, Inc. POSASR - - POST EFFECTIVE AMENDMENT NO. 1 TO FORM S-3

POSASR 1 d888077dposasr.htm POST EFFECTIVE AMENDMENT NO. 1 TO FORM S-3 As filed with the Securities and Exchange Commission on February 14, 2020 Registration No. 333-231871 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-3 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 CORTEVA, INC. (Exact name of registrant as specified in

Form of Indenture for debt securities between E.I. du Pont de Nemours and Company and U.S. Bank National Association.

EX-4.4 Exhibit 4.4 E.I. du Pont de Nemours and Company INDENTURE Dated as of 20[ ] DEBT SECURITIES U.S. Bank National Association Trustee Reconciliation and tie between Trust Indenture Act of 1939 and Indenture* Trust Indenture Act Section Indenture Section § 310 (a) 11.04(a), 17.02 (b) 11.01(g), 11.04(b), 11.05(1), 17.02 (b)(i) 11.04(b), 17.02 § 311 11.01(g), 17.02 § 312 14.02(d), 17.02 (b) 11.10

Annual Report - 10-K

2019 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2019 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number 001-38710 Corteva, Inc. (Exact Name of Registrant as S

DESCRIPTION OF CORTEVA, INC. COMMON STOCK

Exhibit 4.1 DESCRIPTION OF CORTEVA, INC. COMMON STOCK The following summary description of our common stock is based on the provisions of the General Corporation Law of the State of Delaware (the “DGCL”), our certificate of incorporation, as amended, and our bylaws, as amended. This description does not purport to be complete and is qualified in its entirety by reference to the full text of the DG

DESCRIPTION OF E.I. DUPONT DE NEMOURS AND COMPANY PREFERRED STOCK

EX-4.2 3 ctva-12312019xex42.htm EXHIBIT 4.2 Exhibit 4.2 DESCRIPTION OF E.I. DUPONT DE NEMOURS AND COMPANY PREFERRED STOCK The following summary description of our preferred stock is based on the provisions of the General Corporation Law of the State of Delaware (the “DGCL”), our certificate of incorporation, as amended, and our bylaws, as amended. This description does not purport to be complete a

Form of Supplemental Indenture for debt securities between Corteva, Inc. and U.S. Bank National Association (incorporated by reference to Exhibit No. 4.3 to Post-Effective Amendment No. 1 to the Registration Statement on Form S-3, filed on February 14, 2020).

EX-4.3 Exhibit 4.3 Corteva, Inc. SUPPLEMENTAL INDENTURE Dated as of 20[ ] DEBT SECURITIES U.S. Bank National Association Trustee SUPPLEMENTAL INDENTURE (this “Supplemental Indenture”), dated as of , 20 , among Corteva, Inc., a Delaware corporation (the “Company”), each of the parties identified as a Guarantor in Schedule I hereto and U.S. Bank National Association, as trustee (the “Trustee”). WITN

Quarterly Report - 10-Q

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2019 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number 001-38710 Corteva, Inc. (Exact Name of Regi

Quarterly Report - 10-Q

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2019 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number 001-38710 Corteva, Inc. (Exact Name of Registran

Changes in Control of Registrant

8-K 1 dd6319form8-k.htm 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 DATE OF REPORT (Date of Earliest Event Reported): June 3, 2019 (May 31, 2019) E. I. du Pont de Nemours and Company (Exact Name of Registrant as Specified in Its Charter) Delaware 1-815 51-0014090 (State or

Quarterly Report - 10-Q

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2019 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number 1-815 E. I. du Pont de Nemours and Company (Exa

Financial Statements and Exhibits, Completion of Acquisition or Disposition of Assets

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of Earliest Event Reported): May 3, 2019 (May 1, 2019) E. I. du Pont de Nemours and Company (Exact Name of Registrant as Specified in Its Charter) Delaware 1-815 51-0014090 (State or Other Jurisdiction (Commissio

The Dow Agricultural Sciences Business COMBINED FINANCIAL STATEMENTS For the years ended December 31, 2018, 2017 and 2016 TABLE OF CONTENTS Independent Auditors Report 2 Combined Statements of Income and Comprehensive Income 4 Combined Balance Sheets

EX-99.2 4 exhibit992.htm EXHIBIT 99.2 Exhibit 99.2 The Dow Agricultural Sciences Business COMBINED FINANCIAL STATEMENTS For the years ended December 31, 2018, 2017 and 2016 TABLE OF CONTENTS Independent Auditors Report 2 Combined Statements of Income and Comprehensive Income 4 Combined Balance Sheets 5 Combined Statements of Cash Flows 6 Combined Statements of Equity 7 Notes to the Combined Financ

UNAUDITED PRO FORMA COMBINED FINANCIAL STATEMENTS

EX-99.1 3 exhibit991.htm EXHIBIT 99.1 UNAUDITED PRO FORMA COMBINED FINANCIAL STATEMENTS DowDuPont Inc. ("DowDuPont") was formed on December 9, 2015, to effect an all-stock merger of equals strategic combination between The Dow Chemical Company ("Historical Dow") and E. I. du Pont de Nemours and Company ("Historical DuPont" or the "company"). On August 31, 2017 at 11:59 pm ET, (the "Merger Effectiv

Other Events

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of Earliest Event Reported): March 22, 2019 E. I. du Pont de Nemours and Company (Exact Name of Registrant as Specified in Its Charter) Delaware 1-815 51-0014090 (State or Other Jurisdiction (Commission (I.R.S. E

CONFLICT MINERALS REPORT E. I. DU PONT DE NEMOURS AND COMPANY For the reporting period from January 1, 2018 to December 31, 2018

EX-1.01 2 dd-123118sdexx101.htm EXHIBIT 1.01 Exhibit 1.01 CONFLICT MINERALS REPORT E. I. DU PONT DE NEMOURS AND COMPANY For the reporting period from January 1, 2018 to December 31, 2018 This Conflict Minerals Report (the “Report”) of E. I. du Pont de Nemours and Company, (“EID” or the “Company”) has been prepared pursuant to Rule 13p-1 and Form SD (the “Rule”) promulgated under the Securities and

DD / Du Pont (E.I.) De Nemours & Co., Inc. SD

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM SD Specialized Disclosure Report E. I. du Pont de Nemours and Company (Exact Name of Registrant as Specified in Its Charter) Delaware 1-815 51-0014090 (State or Other Jurisdiction (Commission (I.R.S. Employer Of Incorporation) File Number) Identification No.) 974 Centre Road Wilmington, Delaware 19805 (Address of principa

DD / Du Pont (E.I.) De Nemours & Co., Inc. 10-K (Annual Report)

2018 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K (Mark One) ý ANNUAL REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2018 OR o TRANSITION REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number 1-815 E. I. DU PONT DE NEMOURS AND COMPANY (Exact name

SUBSIDIARIES OF THE REGISTRANT Set forth below are certain subsidiaries of E. I. du Pont de Nemours and Company Name Organized Under Laws Of AG Orion Holding B.V. The Netherlands Belco Technologies Corporation Delaware DACI Investments, LLC Delaware

Exhibit 21 SUBSIDIARIES OF THE REGISTRANT Set forth below are certain subsidiaries of E.

DD / Du Pont (E.I.) De Nemours & Co., Inc. 10-Q (Quarterly Report)

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2018 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number 1-815 E. I. du Pont de Nemours and Company

E. I. DU PONT DE NEMOURS AND COMPANY COMPUTATION OF RATIO OF EARNINGS TO FIXED CHARGES (Dollars in millions)

EX-12 2 dd-9302018xex12.htm EX-12 Exhibit 12 E. I. DU PONT DE NEMOURS AND COMPANY COMPUTATION OF RATIO OF EARNINGS TO FIXED CHARGES (Dollars in millions) Successor Predecessor Nine Months Ended September 30, 2018 For the Period September 1 - September 1, 2017 For the Period January 1 - August 31, 2017 (Loss) income from continuing operations before income taxes $ (4,482 ) $ (298 ) $ 1,791 Adjustme

Material Impairments

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of Earliest Event Reported): October 18, 2018 (October 12, 2018) E. I. du Pont de Nemours and Company (Exact Name of Registrant as Specified in Its Charter) Delaware 1-815 51-0014090 (State or Other Jurisdiction

DD / Du Pont (E.I.) De Nemours & Co., Inc. 10-Q (Quarterly Report)

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2018 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number 1-815 E. I. du Pont de Nemours and Company (Exac

EX-12

Exhibit 12 E. I. DU PONT DE NEMOURS AND COMPANY COMPUTATION OF RATIO OF EARNINGS TO FIXED CHARGES (Dollars in millions) Successor Predecessor Six Months Ended June 30, 2018 Six Months Ended June 30, 2017 Income from continuing operations before income taxes $ 466 $ 2,181 Adjustment for companies accounted for by the equity method 76 (30 ) Less: Capitalized interest (9 ) (13 ) Add: Amortization of

DD / Du Pont (E.I.) De Nemours & Co., Inc. SD

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM SD Specialized Disclosure Report E. I. du Pont de Nemours and Company (Exact Name of Registrant as Specified in Its Charter) Delaware 1-815 51-0014090 (State or Other Jurisdiction (Commission (I.R.S. Employer Of Incorporation) File Number) Identification No.) 974 Centre Road Wilmington, Delaware 19805 (Address of principa

CONFLICT MINERALS REPORT E. I. DU PONT DE NEMOURS AND COMPANY For the reporting period from January 1, 2017 to December 31, 2017

Exhibit 1.01 CONFLICT MINERALS REPORT E. I. DU PONT DE NEMOURS AND COMPANY For the reporting period from January 1, 2017 to December 31, 2017 This Conflict Minerals Report (the “Report”) of E. I. du Pont de Nemours and Company, (“DuPont” or the “Company”) has been prepared pursuant to Rule 13p-1 and Form SD (the “Rule”) promulgated under the Securities and Exchange Act of 1934, as amended, for the

DD / Du Pont (E.I.) De Nemours & Co., Inc. 10-Q (Quarterly Report)

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2018 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number 1-815 E. I. du Pont de Nemours and Company (Exa

E. I. DU PONT DE NEMOURS AND COMPANY COMPUTATION OF RATIO OF EARNINGS TO FIXED CHARGES (Dollars in millions)

Exhibit 12 E. I. DU PONT DE NEMOURS AND COMPANY COMPUTATION OF RATIO OF EARNINGS TO FIXED CHARGES (Dollars in millions) Successor Predecessor Three Months Ended March 31, 2018 Three Months Ended March 31, 2017 (Loss) Income from continuing operations before income taxes $ (189 ) $ 1,375 Adjustment for companies accounted for by the equity method 87 (17 ) Less: Capitalized interest (4 ) (7 ) Add: A

SUBSIDIARIES OF THE REGISTRANT Set forth below are certain subsidiaries of E. I. du Pont de Nemours and Company Name Organized Under Laws Of Belco Technologies Corporation Delaware DPC (Luxembourg) SARL Luxembourg DPNL BV The Netherlands Du Pont (Aus

EX-21 5 dd-12312017xex21.htm EX-21 Exhibit 21 SUBSIDIARIES OF THE REGISTRANT Set forth below are certain subsidiaries of E. I. du Pont de Nemours and Company Name Organized Under Laws Of Belco Technologies Corporation Delaware DPC (Luxembourg) SARL Luxembourg DPNL BV The Netherlands Du Pont (Australia) PTY LTD. Australia Du Pont Agricultural Chemicals Ltd., Shanghai China Du Pont China Limited (US

MASTER FRAMEWORK AGREEMENT

Execution Version MASTER FRAMEWORK AGREEMENT This MASTER FRAMEWORK AGREEMENT (this “Framework Agreement”), is made and entered into as of February 13, 2018 (the “Effective Date”), by and among: Coöperatieve Rabobank, U.

E. I. DU PONT DE NEMOURS AND COMPANY COMPUTATION OF RATIO OF EARNINGS TO FIXED CHARGES (Dollars in millions)

Exhibit 12 E. I. DU PONT DE NEMOURS AND COMPANY COMPUTATION OF RATIO OF EARNINGS TO FIXED CHARGES (Dollars in millions) Successor Predecessor 9/1/17-12/31/17 1/1/17-8/31/17 2016 2015 2014 2013 (Loss) Income from continuing operations before income taxes $ (1,586 ) $ 1,791 $ 2,723 $ 2,022 $ 3,564 $ 1,857 Adjustment for companies accounted for by the equity method 33 (42 ) (23 ) 39 150 63 Less: Capi

[Signature Pages Follow]

Master Repurchase Agreement September 1996 Version Dated as of February 13, 2018 Between: Coöperatieve Rabobank, U.

DD / Du Pont (E.I.) De Nemours & Co., Inc. 10-K (Annual Report)

2017 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K (Mark One) ý ANNUAL REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2017 OR o TRANSITION REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number 1-815 E. I. DU PONT DE NEMOURS AND COMPANY (Exact name

E. I. DU PONT DE NEMOURS AND COMPANY COMPUTATION OF RATIO OF EARNINGS TO FIXED CHARGES (Dollars in millions)

Exhibit 12 E. I. DU PONT DE NEMOURS AND COMPANY COMPUTATION OF RATIO OF EARNINGS TO FIXED CHARGES (Dollars in millions) Successor Predecessor For the Period September 1 - September 30, 2017 For the Period January 1 - August 31, 2017 Nine Months Ended September 30, 2016 Income from continuing operations before income taxes $ (298 ) $ 1,791 $ 2,474 Adjustment for companies accounted for by the equit

UNAUDITED PRO FORMA CONSOLIDATED FINANCIAL INFORMATION

Exhibit 99.1 UNAUDITED PRO FORMA CONSOLIDATED FINANCIAL INFORMATION On March 31, 2017, E. I. du Pont de Nemours and Company ("DuPont" or the "company") entered into a definitive agreement with FMC Corporation ("FMC") for the acquisition of the Crop Protection business and R&D assets (the "Divested Ag Business") that DuPont is required to divest to obtain European Commission ("EC") approval of the

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q

10-Q 1 dd-2017930x10q.htm 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2017 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number 1-815 E. I.

Costs Associated with Exit or Disposal Activities

Document UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of Earliest Event Reported): November 2, 2017 (November 1, 2017) E. I. du Pont de Nemours and Company (Exact Name of Registrant as Specified in Its Charter) Delaware 1-815 51-0014090 (State or Other Juri

Du Pont (E.I.) De Nemours S-8 POS

S-8 POS As filed with the Securities and Exchange Commission on September 1, 2017 Registration No.

Du Pont (E.I.) De Nemours S-8 POS

S-8 POS As filed with the Securities and Exchange Commission on September 1, 2017 Registration No.

Du Pont (E.I.) De Nemours S-8 POS

S-8 POS 1 d451121ds8pos.htm S-8 POS As filed with the Securities and Exchange Commission on September 1, 2017 Registration No. 333-195452 Registration No. 333-195451 Registration No. 333-172151 Registration No. 333-164989 Registration No. 333-164988 Registration No. 333-164987 Registration No. 333-150605 Registration No. 333-147452 Registration No. 333-145038 Registration No. 333-144083 Registrati

Du Pont (E.I.) De Nemours S-8 POS

S-8 POS As filed with the Securities and Exchange Commission on September 1, 2017 Registration No.

Du Pont (E.I.) De Nemours S-8 POS

S-8 POS As filed with the Securities and Exchange Commission on September 1, 2017 Registration No.

Du Pont (E.I.) De Nemours S-8 POS

S-8 POS As filed with the Securities and Exchange Commission on September 1, 2017 Registration No.

Du Pont (E.I.) De Nemours S-8 POS

As filed with the Securities and Exchange Commission on September 1, 2017 Registration No.

Du Pont (E.I.) De Nemours S-8 POS

S-8 POS As filed with the Securities and Exchange Commission on September 1, 2017 Registration No.

Du Pont (E.I.) De Nemours S-8 POS

S-8 POS As filed with the Securities and Exchange Commission on September 1, 2017 Registration No.

Du Pont (E.I.) De Nemours S-8 POS

S-8 POS As filed with the Securities and Exchange Commission on September 1, 2017 Registration No.

Du Pont (E.I.) De Nemours S-8 POS

S-8 POS As filed with the Securities and Exchange Commission on September 1, 2017 Registration No.

Du Pont (E.I.) De Nemours S-8 POS

S-8 POS As filed with the Securities and Exchange Commission on September 1, 2017 Registration No.

Du Pont (E.I.) De Nemours S-8 POS

S-8 POS As filed with the Securities and Exchange Commission on September 1, 2017 Registration No.

Du Pont (E.I.) De Nemours S-8 POS

S-8 POS As filed with the Securities and Exchange Commission on September 1, 2017 Registration No.

Du Pont (E.I.) De Nemours S-8 POS

S-8 POS As filed with the Securities and Exchange Commission on September 1, 2017 Registration No.

Du Pont (E.I.) De Nemours S-8 POS

S-8 POS As filed with the Securities and Exchange Commission on September 1, 2017 Registration No.

Du Pont (E.I.) De Nemours S-8 POS

S-8 POS As filed with the Securities and Exchange Commission on September 1, 2017 Registration No.

Du Pont (E.I.) De Nemours S-8 POS

S-8 POS As filed with the Securities and Exchange Commission on September 1, 2017 Registration No.

Du Pont (E.I.) De Nemours S-8 POS

S-8 POS As filed with the Securities and Exchange Commission on September 1, 2017 Registration No.

Du Pont (E.I.) De Nemours S-8 POS

S-8 POS As filed with the Securities and Exchange Commission on September 1, 2017 Registration No.

Du Pont (E.I.) De Nemours S-8 POS

S-8 POS 1 d451121ds8pos.htm S-8 POS As filed with the Securities and Exchange Commission on September 1, 2017 Registration No. 333-195452 Registration No. 333-195451 Registration No. 333-172151 Registration No. 333-164989 Registration No. 333-164988 Registration No. 333-164987 Registration No. 333-150605 Registration No. 333-147452 Registration No. 333-145038 Registration No. 333-144083 Registrati

Du Pont (E.I.) De Nemours S-8 POS

S-8 POS As filed with the Securities and Exchange Commission on September 1, 2017 Registration No.

Du Pont (E.I.) De Nemours S-8 POS

S-8 POS 1 d451121ds8pos.htm S-8 POS As filed with the Securities and Exchange Commission on September 1, 2017 Registration No. 333-195452 Registration No. 333-195451 Registration No. 333-172151 Registration No. 333-164989 Registration No. 333-164988 Registration No. 333-164987 Registration No. 333-150605 Registration No. 333-147452 Registration No. 333-145038 Registration No. 333-144083 Registrati

Du Pont (E.I.) De Nemours S-8 POS

S-8 POS As filed with the Securities and Exchange Commission on September 1, 2017 Registration No.

Du Pont (E.I.) De Nemours S-8 POS

S-8 POS As filed with the Securities and Exchange Commission on September 1, 2017 Registration No.

Du Pont (E.I.) De Nemours S-8 POS

S-8 POS As filed with the Securities and Exchange Commission on September 1, 2017 Registration No.

Du Pont (E.I.) De Nemours S-8 POS

S-8 POS As filed with the Securities and Exchange Commission on September 1, 2017 Registration No.

Du Pont (E.I.) De Nemours S-8 POS

S-8 POS As filed with the Securities and Exchange Commission on September 1, 2017 Registration No.

Du Pont (E.I.) De Nemours S-8 POS

S-8 POS As filed with the Securities and Exchange Commission on September 1, 2017 Registration No.

Amended and Restated Bylaws of E.I. du Pont de Nemours and Company (incorporated by reference to Exhibit 3.2 to E.I. du Pont de Nemours and Company’s Current Report on Form 8-K, filed on September 1, 2017).

EX-3.2 3 d438565dex32.htm EX-3.2 Exhibit 3.2 AMENDED AND RESTATED BYLAWS OF E. I. DU PONT DE NEMOURS AND COMPANY (a Delaware corporation) ARTICLE I Stockholders SECTION 1. Annual Meetings. The annual meeting of stockholders of E. I. du Pont de Nemours and Company, a Delaware corporation (the “Corporation”) for the election of directors and for the transaction of such other business as may properly

Employment Agreement by and between E. I. du Pont de Nemours and Company, and Edward D. Breen, dated as of August 3, 2017, incorporated by reference to Exhibit 10.1 to the E. I. du Pont de Nemours and Company Current Report on Form 8-K dated September 1, 2017.

EX-10.1 4 d438565dex101.htm EX-10.1 Exhibit 10.1 EMPLOYMENT AGREEMENT This EMPLOYMENT AGREEMENT (this “Agreement”) is hereby entered into as of August 31, 2017 by and between E. I. du Pont de Nemours and Company (“DuPont”) and Edward D. Breen, an individual (the “Executive” and, together with DuPont, the “Parties” and each a “Party”). RECITALS WHEREAS, pursuant to the transactions contemplated by

Fourth Amended and Restated Certificate of Incorporation of E.I. du Pont de Nemours and Company (incorporated by reference to Exhibit 3.1 to E.I. du Pont de Nemours and Company’s Current Report on Form 8-K, filed on September 1, 2017).

EX-3.1 2 d438565dex31.htm EX-3.1 Exhibit 3.1 FOURTH AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF E. I. DU PONT DE NEMOURS AND COMPANY FIRST: The name of the corporation is E. I. du Pont de Nemours and Company (the “Corporation”). SECOND: The address of the registered office of the Corporation in the State of Delaware is: Corporation Trust Center, 1209 Orange Street, Wilmington, DE 19801, C

Changes in Control of Registrant, Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Material Modification to Rights of Security Holders, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Financial Statements and Exhibits, Completion of Acquisition or Disposition of Assets, Other Events

8-K 1 d438565d8k.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 DATE OF REPORT (Date of earliest event reported): September 1, 2017 (August 31, 2017) E. I. du Pont de Nemours and Company (Exact name of registrant as specified in its charter) Delaware 1-815 51-0014090

EX-99.25

NOTIFICATION OF THE REMOVAL FROM LISTING AND REGISTRATION OF THE STATED SECURITIES The New York Stock Exchange hereby notifies the SEC of its intention to remove the entire class of the stated securities from listing and registration on the Exchange at the opening of business on September 12, 2017, pursuant to the provisions of Rule 12d2-2 (a).

Amendment No. 1 to Separation Agreement by and between E. I. du Pont de Nemours and Company and The Chemours Company, dated August 24, 2017 (incorporated by reference to Exhibit 2.1 to E. I. du Pont de Nemours and Company’s Current Report on Form 8-K (Commission file number 1-815) dated August 25, 2017).

EX-2.1 2 exhibit2x1.htm EX-2.1 Exhibit 2.1 AMENDMENT NUMBER 1 TO SEPARATION AGREEMENT This Amendment Number 1 (this “Amendment”) to the Separation Agreement (as defined below), dated as of August 24, 2017, is entered into by and between E. I. du Pont de Nemours and Company (“DuPont”), a Delaware corporation, and The Chemours Company (“Chemours”), a Delaware corporation. “Party” or “Parties” means

Du Pont (E.I.) De Nemours 8-K (Current Report/Significant Event)

Document UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of Earliest Event Reported): August 25, 2017 (August 24, 2017) E. I. du Pont de Nemours and Company (Exact Name of Registrant as Specified in Its Charter) Delaware 1-815 51-0014090 (State or Other Jurisd

Entry into a Material Definitive Agreement, Financial Statements and Exhibits, Other Events

8-K 1 a17-1898518k.htm 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 DATE OF REPORT (Date of earliest event reported): August 4, 2017 (August 2, 2017) E. I. du Pont de Nemours and Company (Exact name of registrant as specified in its charter) Delaware 1-815 51-0014090 (State

DuPont and Dow Set Closing Date for Merger of Equals —All Conditions Satisfied — — Merger Will Close August 31, 2017 —

EX-99.1 3 a17-189851ex99d1.htm EX-99.1 Exhibit 99.1 DuPont and Dow Set Closing Date for Merger of Equals —All Conditions Satisfied — — Merger Will Close August 31, 2017 — WILMINGTON, Del. and MIDLAND, Mich., August 4, 2017— DuPont (NYSE: DD) and The Dow Chemical Company (NYSE: DOW) announced today that all required regulatory approvals and clearances have been received, that all conditions to clos

[Signature Page Follows]

EX-2.1 2 a17-189851ex2d1.htm EX-2.1 Exhibit 2.1 August 4, 2017 E. I. du Pont de Nemours and Company Attn: Stacy L. Fox Chestnut Run Plaza, 974 Centre Road Wilmington, Delaware 19805 Re: Merger Agreement - Closing Date Ladies and Gentlemen, Reference is hereby made to that certain Agreement and Plan of Merger, dated as of December 11, 2015, as amended on March 31, 2017, by and among The Dow Chemica

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2017 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number 1-815 E. I. du Pont de Nemours and Company (Exac

0 DuPont First Quarter 2017 Earnings CONFERENCE CALL APRIL 25TH, 2017 DuPont Second-Quarter 2017 Earnings CONFERENCE CALL JULY 25TH, 2017 1 Regulation G This document includes information that does not conform to U.S. generally accepted accounting pr

0 DuPont First Quarter 2017 Earnings CONFERENCE CALL APRIL 25TH, 2017 DuPont Second-Quarter 2017 Earnings CONFERENCE CALL JULY 25TH, 2017 1 Regulation G This document includes information that does not conform to U.

E. I. DU PONT DE NEMOURS AND COMPANY COMPUTATION OF RATIO OF EARNINGS TO FIXED CHARGES (Dollars in millions)

EX-12 3 dd-ex122017630xq2.htm EX-12 Exhibit 12 E. I. DU PONT DE NEMOURS AND COMPANY COMPUTATION OF RATIO OF EARNINGS TO FIXED CHARGES (Dollars in millions) Six Months Ended June 30, 2017 2016 Income from continuing operations before income taxes $ 2,549 $ 2,968 Adjustment for companies accounted for by the equity method (30 ) (19 ) Less: Capitalized interest (13 ) (12 ) Add: Amortization of capita

DuPont Reports Second-Quarter and First-Half Results Volume Gains Drove 5-Percent Sales Growth Segment Operating Margin Expansion Continued Merger of Equals with Dow Expected to Close in August Second-Quarter Highlights

Exhibit 99.1 July 25, 2017 Media Contact: Dan Turner WILMINGTON, Del. 302-996-8372 [email protected] Investor Contact: 302-774-4994 DuPont Reports Second-Quarter and First-Half Results Volume Gains Drove 5-Percent Sales Growth Segment Operating Margin Expansion Continued Merger of Equals with Dow Expected to Close in August Second-Quarter Highlights • GAAP1 earnings per share decreased 16

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of Earliest Event Reported): July 25, 2017 E. I. du Pont de Ne

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of Earliest Event Reported): July 25, 2017 E. I. du Pont de Nemours and Company (Exact Name of Registrant as Specified in Its Charter) Delaware 1-815 51-0014090 (State or Other Jurisdiction (Commission (I.R.S. Em

EX-10.26

EXECUTION VERSION FMC CORPORATION 2929 Walnut Street Philadelphia, Pennsylvania 19104 May 12, 2017 E.

Du Pont (E.I.) De Nemours 11-K

Document Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 11-K (Mark One) x ANNUAL REPORT PURSUANT TO SECTION 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2016 OR o TRANSITION REPORT PURSUANT TO SECTION 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number 1-815 DUPONT RETIREMENT SAVINGS PLAN (Full title of plan) E.

Du Pont (E.I.) De Nemours SD

Document UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM SD Specialized Disclosure Report E. I. du Pont de Nemours and Company (Exact Name of Registrant as Specified in Its Charter) Delaware 1-815 51-0014090 (State or Other Jurisdiction (Commission (I.R.S. Employer Of Incorporation) File Number) Identification No.) 974 Centre Road Wilmington, Delaware 19805 (Address of

Submission of Matters to a Vote of Security Holders

8-K 1 dd52417form8-k.htm 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of Earliest Event Reported): May 25, 2017 (May 24, 2017) E. I. du Pont de Nemours and Company (Exact Name of Registrant as Specified in Its Charter) Delaware 1-815 51-0014090 (State o

Financial Statements and Exhibits, Other Events

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of Earliest Event Reported): May 2, 2017 (May 2, 2017) E. I. du Pont de Nemours and Company (Exact Name of Registrant as Specified in Its Charter) Delaware 1-815 51-0014090 (State or Other Jurisdiction (Commissio

CALCULATION OF REGISTRATION FEE Title of Each Class of Securities to be Registered Amount to be Registered Proposed Maximum Offering Price Per Share Proposed Maximum Aggregate Offering Price Amount of Registration Fee(2) Debt Securities $2,000,000,00

424B2 Table of Contents CALCULATION OF REGISTRATION FEE Title of Each Class of Securities to be Registered Amount to be Registered Proposed Maximum Offering Price Per Share Proposed Maximum Aggregate Offering Price Amount of Registration Fee(2) Debt Securities $2,000,000,000 (1) $1,998,625,000 $231,640.

E. I. du Pont de Nemours and Company $1,250,000,000 2.200% Notes due May 1, 2020 $750,000,000 Floating Rate Notes due May 1, 2020 Issuer: E. I. du Pont de Nemours and Company Title of Securities: 2.200% Notes due 2020: (the “Fixed Rate Notes”) Floati

FWP 1 d376647dfwp.htm FWP Filed Pursuant to Rule 433 Registration Statement No. 333-215864 Pricing Term Sheet April 27, 2017 E. I. du Pont de Nemours and Company $1,250,000,000 2.200% Notes due May 1, 2020 $750,000,000 Floating Rate Notes due May 1, 2020 Issuer: E. I. du Pont de Nemours and Company Title of Securities: 2.200% Notes due 2020: (the “Fixed Rate Notes”) Floating Rate Notes due 2020: (

Subject to Completion Dated April 26, 2017

424B3 1 d376647d424b3.htm 424B3 Table of Contents Filed pursuant to Rule 424(b)(3) Registration Statement No. 333-215864 The information in this preliminary prospectus supplement is not complete and may be changed. This preliminary prospectus supplement is neither an offer to sell these securities nor a solicitation of an offer to buy these securities in any jurisdiction in which the offer or sale

Du Pont (E.I.) De Nemours 10-Q (Quarterly Report)

10-Q 1 dd-2017331x10q.htm 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2017 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number 1-815 E. I. du P

EX-10.16

EX-10.16 2 dd-ex10162017331xq1.htm EX-10.16 Exhibit 10.16 AWARD TERMS OF OPTIONS GRANTED UNDER THE DUPONT EQUITY AND INCENTIVE PLAN FOR GRANTEES LOCATED IN THE U.S. Introduction You have been granted stock options under the E. I. du Pont de Nemours and Company Equity and Incentive Plan (“Plan”), subject to the following Award Terms. This grant is also subject to the terms of the Plan, which is her

DuPont Reports First-Quarter Results GAAP1 EPS Increased 9 Percent; Operating2 EPS Increased 30 Percent Total Company Sales Grew 5 Percent on Volume and Price Improvement Segment Operating Margins Expanded About 250 Basis Points First-Quarter Highlig

EX-99.1 2 a33117enr.htm EX - 99.1 Exhibit 99.1 April 25, 2017 Media Contact: Dan Turner WILMINGTON, Del. 302-996-8372 [email protected] Investor Contact: 302-774-4994 DuPont Reports First-Quarter Results GAAP1 EPS Increased 9 Percent; Operating2 EPS Increased 30 Percent Total Company Sales Grew 5 Percent on Volume and Price Improvement Segment Operating Margins Expanded About 250 Basis Po

0 DuPont First Quarter 2017 Earnings CONFERENCE CALL APRIL 25TH, 2017 DuPont First-Quarter 2017 Earnings CONFERENCE CALL APRIL 25TH, 2017 1 Regulation G This document includes information that does not conform to U.S. generally accepted accounting pr

EX-99.2 3 dupont1q17slidesfinal.htm EX - 99.2 0 DuPont First Quarter 2017 Earnings CONFERENCE CALL APRIL 25TH, 2017 DuPont First-Quarter 2017 Earnings CONFERENCE CALL APRIL 25TH, 2017 1 Regulation G This document includes information that does not conform to U.S. generally accepted accounting principles (GAAP) and are considered non-GAAP measures. These measures include the company’s consolidated

Financial Statements and Exhibits, Results of Operations and Financial Condition

8-K 1 a331178kenr.htm 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of Earliest Event Reported): April 25, 2017 E. I. du Pont de Nemours and Company (Exact Name of Registrant as Specified in Its Charter) Delaware 1-815 51-0014090 (State or Other Jurisdic

Transaction Agreement, dated as of March 31, 2017, by and between E. I. du Pont de Nemours and Company and FMC Corporation (incorporated by reference to Exhibit 10.25 to E. I. du Pont de Nemours and Company’s Quarterly Report on Form 10-Q (Commission file number 1-815) for the period ended March 31, 2017).

Exhibit 10.25 TRANSACTION AGREEMENT BY AND BETWEEN E. I. du Pont de Nemours and Company AND FMC Corporation Dated as of March 31, 2017 1414958.12A-NYCSR03A - MSW TABLE OF CONTENTS Article I DEFINITIONS 1 Section 1.1 Definitions 1 Section 1.2 Defined Terms 26 Article II CLOSING 36 Section 2.1 Closing 36 Section 2.2 Closing Date 36 Section 2.3 Acquired Ag Assets 39 Section 2.4 Excluded Ag Assets 40

E. I. DU PONT DE NEMOURS AND COMPANY COMPUTATION OF RATIO OF EARNINGS TO FIXED CHARGES (Dollars in millions)

Exhibit 12 E. I. DU PONT DE NEMOURS AND COMPANY COMPUTATION OF RATIO OF EARNINGS TO FIXED CHARGES (Dollars in millions) Three Months Ended March 31, 2017 2016 Income from continuing operations before income taxes $ 1,562 $ 1,635 Adjustment for companies accounted for by the equity method (17 ) (2 ) Less: Capitalized interest (7 ) (6 ) Add: Amortization of capitalized interest 7 7 1,545 1,634 Fixed

EX-10.23

EX-10.23 3 dd-ex10232017331xq1.htm EX-10.23 Exhibit 10.23 AWARD TERMS OF OPTIONS GRANTED UNDER THE DUPONT EQUITY AND INCENTIVE PLAN FOR GRANTEES LOCATED IN THE U.S. Introduction You have been granted stock options under the E. I. du Pont de Nemours and Company Equity and Incentive Plan (“Plan”), subject to the following Award Terms. This grant is also subject to the terms of the Plan, which is her

Du Pont (E.I.) De Nemours DEFA14A

DEFA14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ? Filed by a Party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))

Du Pont (E.I.) De Nemours DEF 14A

DEF 14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ? Filed by a Party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))

Regulation FD Disclosure, Entry into a Material Definitive Agreement, Financial Statements and Exhibits

8-K 1 d379338d8k.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of Earliest Event Reported): March 31, 2017 E. I. du Pont de Nemours and Company (Exact Name of Registrant as Specified in Its Charter) Delaware 1-815 51-0014090 (State or Other Juri

AMENDMENT NO. 1 TO AGREEMENT AND PLAN OF MERGER

EX-2.1 2 d379338dex21.htm EX-2.1 Exhibit 2.1 AMENDMENT NO. 1 TO AGREEMENT AND PLAN OF MERGER This AMENDMENT NO. 1 TO AGREEMENT AND PLAN OF MERGER (this “Amendment”), dated as of March 31, 2017, is by and among The Dow Chemical Company, a Delaware corporation (“Dow”), E. I. du Pont de Nemours and Company, a Delaware corporation (“DuPont”), DowDuPont Inc., a Delaware corporation f/k/a Diamond-Orion

DuPont Announces Agreement with FMC – DuPont to Divest a Portion of Its Crop Protection Business and Acquire FMC’s Health & Nutrition Business – – Transaction Marks Meaningful Step Forward in Proposed DuPont and Dow Merger; Maintains Significant Stra

EX-99.1 3 d379338dex991.htm EX-99.1 Exhibit 99.1 DuPont Announces Agreement with FMC – DuPont to Divest a Portion of Its Crop Protection Business and Acquire FMC’s Health & Nutrition Business – – Transaction Marks Meaningful Step Forward in Proposed DuPont and Dow Merger; Maintains Significant Strategic Value Creation Potential of Merger Transaction – – Merger with Dow Now Expected to Close Betwee

Cautionary Notes on Forward Looking Statements This communication contains “forward-looking statements” within the meaning of the federal securities laws, including Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securit

EX-99.3 5 d379338dex993.htm EX-99.3 Summary of Transactions with FMC: Divestiture of Certain Crop Protection Assets and Acquisition of FMC’s Health & Nutrition Business 1 March 31, 2017 Exhibit 99.3 Cautionary Notes on Forward Looking Statements This communication contains “forward-looking statements” within the meaning of the federal securities laws, including Section 27A of the Securities Act of

Dow and DuPont Announce Amendments to Transaction Merger Agreement

EX-99.2 4 d379338dex992.htm EX-99.2 Exhibit 99.2 Dow and DuPont Announce Amendments to Transaction Merger Agreement • Dow and DuPont Amend Merger Agreement to Reflect Extension to August 31; Close of Transaction Now Expected No Earlier than August 1 • Dow and DuPont Reiterate Intended Spin-offs Will Occur Within 18 Months After Closing • Material Science Company Now Expected to be the First Spin-o

Regulation FD Disclosure, Financial Statements and Exhibits

8-K 1 a327178k.htm 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of Earliest Event Reported): March 27, 2017 E. I. du Pont de Nemours and Company (Exact Name of Registrant as Specified in Its Charter) Delaware 1-815 51-0014090 (State or Other Jurisdictio

Dow and DuPont Receive Conditional Approval from European Commission for Proposed Merger of Equals -- Represents Significant Milestone in Merger and Intention to Separate into Three Strong, Independent Companies-- --Transaction Still Expected to Crea

Exhibit Exhibit 99.1 Dow and DuPont Receive Conditional Approval from European Commission for Proposed Merger of Equals - Represents Significant Milestone in Merger and Intention to Separate into Three Strong, Independent Companies- -Transaction Still Expected to Create Significant Cost Synergies of $3B with $1B in Growth Synergies- WILMINGTON, Del. and MIDLAND, Mich., March 27, 2017 - DuPont (NYS

DuPont and Dow Announce Conditional Approval from European Commission March 27, 2017 SEC Disclosure Rules Cautionary Notes on Forward-Looking Statements This communication contains “forward-looking statements” within the meaning of the federal securi

ecannoucementmarch262017 DuPont and Dow Announce Conditional Approval from European Commission March 27, 2017 SEC Disclosure Rules Cautionary Notes on Forward-Looking Statements This communication contains ?forward-looking statements? within the meaning of the federal securities laws, including Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended.

Financial Statements and Exhibits, Other Events

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of Earliest Event Reported): February 13, 2017 (February 11, 2017) E. I. du Pont de Nemours and Company (Exact Name of Registrant as Specified in Its Charter) Delaware 1-815 51-0014090 (State or Other Jurisdictio

DuPont Reaches Global Settlement of Multi-District PFOA Litigation

Exhibit 99.1 Contact: Dan Turner 302-996-8372 [email protected] DuPont Reaches Global Settlement of Multi-District PFOA Litigation WILMINGTON, Del., Feb. 13, 2017 ? DuPont and plaintiffs? attorneys in the Ohio multi-district litigation (MDL) have jointly agreed to a settlement in principle of the MDL involving about 3,550 lawsuits related to PFOA personal injury claims arising from enviro

263534109 / DuPont de Nemours, Inc. / VANGUARD GROUP INC Passive Investment

eidupontdenemoursco.htm - Generated by SEC Publisher for SEC Filing SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 3 )* Name of issuer: EI du Pont de Nemours & Co Title of Class of Securities: Common Stock CUSIP Number: 263534109 Date of Event Which Requires Filing of this Statement: December 31, 2016 Check the appro

SUBSIDIARIES OF THE REGISTRANT Set forth below are certain subsidiaries of E. I. du Pont de Nemours and Company

EX-21 5 dd-12312016xex21.htm EX-21 Exhibit 21 SUBSIDIARIES OF THE REGISTRANT Set forth below are certain subsidiaries of E. I. du Pont de Nemours and Company Name Organized Under Laws Of 1811324 Ontario Limited Canada Belco Technologies Corporation Delaware Coastal Training Technologies Corp. Virginia DPNL BV The Netherlands Du Pont (Australia) PTY LTD. Australia Du Pont Agricultural Chemicals Ltd

E. I. DU PONT DE NEMOURS AND COMPANY COMPUTATION OF RATIO OF EARNINGS TO FIXED CHARGES (Dollars in millions)

Exhibit 12 E. I. DU PONT DE NEMOURS AND COMPANY COMPUTATION OF RATIO OF EARNINGS TO FIXED CHARGES (Dollars in millions) 2016 2015 2014 2013 2012 Income from continuing operations before income taxes $ 3,265 $ 2,591 $ 4,313 $ 2,566 $ 1,290 Adjustment for companies accounted for by the equity method (23 ) 39 150 63 (12 ) Less: Capitalized interest (25 ) (70 ) (56 ) (39 ) (37 ) Add: Amortization of c

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM T-1 STATEMENT OF ELIGIBILITY UNDER THE TRUST INDENTURE ACT OF 1939 OF A CORPORATION DESIGNATED TO ACT AS TRUSTEE CHECK IF AN APPLICATION TO DETERMINE ELIGIBILITY OF A TRUSTE

Exhibit 25.2 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM T-1 STATEMENT OF ELIGIBILITY UNDER THE TRUST INDENTURE ACT OF 1939 OF A CORPORATION DESIGNATED TO ACT AS TRUSTEE CHECK IF AN APPLICATION TO DETERMINE ELIGIBILITY OF A TRUSTEE PURSUANT TO SECTION 305(b)(2) o THE BANK OF NEW YORK MELLON TRUST COMPANY, N.A. (Exact name of trustee as specified in its charter) (Ju

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM T-1

Exhibit 25.1 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM T-1 STATEMENT OF ELIGIBILITY UNDER THE TRUST INDENTURE ACT OF 1939 OF A CORPORATION DESIGNATED TO ACT AS TRUSTEE o CHECK IF AN APPLICATION TO DETERMINE ELIGIBILITY OF A TRUSTEE PURSUANT TO SECTION 305(b)(2) DEUTSCHE BANK TRUST COMPANY AMERICAS (formerly BANKERS TRUST COMPANY) (Exact name of trustee as specifi

Du Pont (E.I.) De Nemours S-3ASR

Use these links to rapidly review the document TABLE OF CONTENTS Table of Contents As filed with the Securities and Exchange Commission on February 2, 2017 Registration No.

DD / DuPont De Nemours & Co., Inc. 10-K - Annual Report - 10-K

10-K 1 dd-12312016x10k.htm 10-K 2016 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K (Mark One) ý ANNUAL REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2016 OR o TRANSITION REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number 1-815 E. I. DU PONT DE

EX-10.22

EX-10.22 3 dd-12312016xex1022.htm EX-10.22 Execution Version MASTER FRAMEWORK AGREEMENT This MASTER FRAMEWORK AGREEMENT (this “Framework Agreement”), is made and entered into as of January 31, 2017 (the “Effective Date”), by and among: Coöperatieve Rabobank, U.A., New York Branch, a Dutch coöperatieve acting through its New York Branch (“Rabobank”) and The Bank of Tokyo-Mitsubishi UFJ, Ltd., New Y

E. I. DU PONT DE NEMOURS AND COMPANY COMPUTATION OF RATIO OF EARNINGS TO FIXED CHARGES (Dollars in millions)

Exhibit 12 E. I. DU PONT DE NEMOURS AND COMPANY COMPUTATION OF RATIO OF EARNINGS TO FIXED CHARGES (Dollars in millions) 2016 2015 2014 2013 2012 Income from continuing operations before income taxes $ 3,265 $ 2,591 $ 4,313 $ 2,566 $ 1,290 Adjustment for companies accounted for by the equity method (23) 39 150 63 (12) Less: Capitalized interest (25) (70) (56) (39) (37) Add: Amortization of capitali

Master Repurchase Agreement

EX-10.21 2 dd-12312016xex1021.htm EX-10.21 Master Repurchase Agreement September 1996 Version Dated as of January 31, 2017 Between: Coöperatieve Rabobank, U.A., New York Branch The Bank of Tokyo-Mitsubishi UFJ, Ltd., New York Branch and PHI Financial Services, Inc. 1. Applicability From time to time the parties hereto may enter into transactions in which one party (“Seller”) agrees to transfer to

Financial Statements and Exhibits, Results of Operations and Financial Condition

8-K 1 a1231168kenr.htm 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of Earliest Event Reported): January 24, 2017 E. I. du Pont de Nemours and Company (Exact Name of Registrant as Specified in Its Charter) Delaware 1-815 51-0014090 (State or Other Juris

0 DuPont Fourth-Quarter and Full-Year 2016 Earnings CONFERENCE CALL JANUARY 24, 2017 1 Regulation G This document includes information that does not conform to U.S. generally accepted accounting principles (GAAP) and are considered non-GAAP measures.

EX-99.2 3 dupont4q16slidesfinal.htm EX-99.2 0 DuPont Fourth-Quarter and Full-Year 2016 Earnings CONFERENCE CALL JANUARY 24, 2017 1 Regulation G This document includes information that does not conform to U.S. generally accepted accounting principles (GAAP) and are considered non-GAAP measures. These measures include the company’s consolidated results and earnings per share on an operating earnings

DuPont Reports Fourth-Quarter and Full-Year Results Full-Year 2016 Earnings Per Share Increased More Than 20 Percent Exceeded 2016 Cost Savings Commitment Full-Year 2016 Free Cash Flow Improved $1.6 Billion Fourth-Quarter Highlights

EX-99.1 2 a123116enr.htm EX-99.1 Exhibit 99.1 January 24, 2017 Media Contact: Dan Turner WILMINGTON, Del. 302-996-8372 [email protected] Investor Contact: 302-774-4994 DuPont Reports Fourth-Quarter and Full-Year Results Full-Year 2016 Earnings Per Share Increased More Than 20 Percent Exceeded 2016 Cost Savings Commitment Full-Year 2016 Free Cash Flow Improved $1.6 Billion Fourth-Quarter H

Du Pont (E.I.) De Nemours 8-K (Current Report/Significant Event)

Document UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of Earliest Event Reported): November 17, 2016 (November 14, 2016) E. I. du Pont de Nemours and Company (Exact Name of Registrant as Specified in Its Charter) Delaware 1-815 51-0014090 (State or Other Ju

E. I. DU PONT DE NEMOURS AND COMPANY COMPUTATION OF RATIO OF EARNINGS TO FIXED CHARGES (Dollars in millions)

Exhibit 12 E. I. DU PONT DE NEMOURS AND COMPANY COMPUTATION OF RATIO OF EARNINGS TO FIXED CHARGES (Dollars in millions) Nine Months Ended September 30, 2016 2015 Income from continuing operations before income taxes $ 2,912 $ 3,012 Adjustment for companies accounted for by the equity method (41 ) 6 Less: Capitalized interest (18 ) (55 ) Add: Amortization of capitalized interest 21 25 2,874 2,988 F

DD / DuPont De Nemours & Co., Inc. 10-Q - Quarterly Report - 10-Q

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2016 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number 1-815 E. I. du Pont de Nemours and Company

0 DuPont Third-Quarter 2016 Earnings CONFERENCE CALL OCTOBER 25, 2016 1 Regulation G This document includes information that does not conform to U.S. generally accepted accounting principles (GAAP) and are considered non-GAAP measures. These measures

EX-99.2 3 dupont3q16slidesfinal.htm EX-99.2 0 DuPont Third-Quarter 2016 Earnings CONFERENCE CALL OCTOBER 25, 2016 1 Regulation G This document includes information that does not conform to U.S. generally accepted accounting principles (GAAP) and are considered non-GAAP measures. These measures include the company’s consolidated results and earnings per share on an operating earnings basis, which e

DuPont Reports Third-Quarter 2016 Results Total Company Sales Grew on 3-Percent Volume Improvement Operating Margins Expanded in all Reportable Segments Increases Full-Year 2016 Operating Earnings Guidance Third-Quarter Highlights

EX-99.1 2 a93016enr.htm EX-99.1 Exhibit 99.1 October 25, 2016 Media Contact: Dan Turner WILMINGTON, Del. 302-996-8372 [email protected] Investor Contact: 302-774-4994 DuPont Reports Third-Quarter 2016 Results Total Company Sales Grew on 3-Percent Volume Improvement Operating Margins Expanded in all Reportable Segments Increases Full-Year 2016 Operating Earnings Guidance Third-Quarter High

Financial Statements and Exhibits, Results of Operations and Financial Condition

Document UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of Earliest Event Reported): October 25, 2016 E. I. du Pont de Nemours and Company (Exact Name of Registrant as Specified in Its Charter) Delaware 1-815 51-0014090 (State or Other Jurisdiction (Commissio

Current Report

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of Earliest Event Reported): September 2, 2016 E. I. du Pont de Nemours and Company (Exact Name of Registrant as Specified in Its Charter) Delaware 1-815 51-0014090 (State or Other Jurisdiction (Commission (I.R.S

Financial Statements and Exhibits, Other Events

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of Earliest Event Reported): August 11, 2016 E. I. du Pont de Nemours and Company (Exact Name of Registrant as Specified in Its Charter) Delaware 1-815 51-0014090 (State or Other Jurisdiction (Commission (I.R.S.

DOW AND DUPONT STATEMENT REGARDING PHASE II REVIEW BY EUROPEAN COMMISSION

Exhibit 99.1 DOW AND DUPONT STATEMENT REGARDING PHASE II REVIEW BY EUROPEAN COMMISSION Wilmington, DE and Midland, MI, August 11, 2016 ? DuPont (NYSE: DD) and The Dow Chemical Company (NYSE: DOW) confirmed today that the European Commission (EC) has initiated a Phase II review for the proposed merger of equals transaction of the two companies. As stated previously, the companies expected a thoroug

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of Earliest Event Reported): July 26, 2016 E. I. du Pont de Ne

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of Earliest Event Reported): July 26, 2016 E. I. du Pont de Nemours and Company (Exact Name of Registrant as Specified in Its Charter) Delaware 1-815 51-0014090 (State or Other Jurisdiction (Commission (I.R.S. Em

0 DuPont Second-Quarter 2016 Earnings CONFERENCE CALL JULY 26, 2016 1 Regulation G This document includes information that does not conform to U.S. generally accepted accounting principles (GAAP) and are considered non-GAAP measures. These measures i

EX-99.2 3 dupont2q16slidesfinal.htm EX-99.2 0 DuPont Second-Quarter 2016 Earnings CONFERENCE CALL JULY 26, 2016 1 Regulation G This document includes information that does not conform to U.S. generally accepted accounting principles (GAAP) and are considered non-GAAP measures. These measures include the company’s consolidated results and earnings per share on an operating earnings basis, which exc

E. I. DU PONT DE NEMOURS AND COMPANY COMPUTATION OF RATIO OF EARNINGS TO FIXED CHARGES (Dollars in millions)

Exhibit 12 E. I. DU PONT DE NEMOURS AND COMPANY COMPUTATION OF RATIO OF EARNINGS TO FIXED CHARGES (Dollars in millions) Six Months Ended June 30, 2016 2015 Income from continuing operations before income taxes $ 2,968 $ 2,785 Adjustment for companies accounted for by the equity method (19 ) 7 Less: Capitalized interest (12 ) (41 ) Add: Amortization of capitalized interest 14 19 2,951 2,770 Fixed c

EX-10.6

E. I. du Pont de Nemours and Company Equity and Incentive Plan (as last amended March 14, 2016) 1 TABLE OF CONTENTS Section Page 1. PURPOSE; TYPES OF AWARDS; CONSTRUCTION. 3 2. DEFINITIONS. 3 3. ADMINISTRATION. 6 4. ELIGIBILITY. 7 5. STOCK SUBJECT TO THE PLAN. 7 6. SPECIFIC TERMS OF AWARDS. 8 7. CHANGE IN CONTROL PROVISIONS. 11 8. GENERAL PROVISIONS. 14 2 E. I. du Pont de Nemours and Company Equit

DD / DuPont De Nemours & Co., Inc. 10-Q - Quarterly Report - 10-Q

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2016 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number 1-815 E. I. du Pont de Nemours and Company (Exac

DuPont Reports Second-Quarter 2016 Results Volumes Grew due to Strength in Agriculture, Performance Materials, and Nutrition & Health Operating Margins Expanded in all Reportable Segments Second-Quarter Highlights

Exhibit 99.1 July 26, 2016 Media Contact: Dan Turner WILMINGTON, Del. 302-996-8372 [email protected] Investor Contact: 302-774-4994 DuPont Reports Second-Quarter 2016 Results Volumes Grew due to Strength in Agriculture, Performance Materials, and Nutrition & Health Operating Margins Expanded in all Reportable Segments Second-Quarter Highlights • GAAP1 earnings per share totaled $1.16 vers

Dow and DuPont Stockholders Approve Merger Companies Achieve Key Milestone in Merger and Subsequent Intended Separation into Three Highly Focused, Independent Companies Wilmington, DE and Midland, MI, July 20, 2016 — DuPont (NYSE:DD) and The Dow Chem

Exhibit 99.1 Dow and DuPont Stockholders Approve Merger Companies Achieve Key Milestone in Merger and Subsequent Intended Separation into Three Highly Focused, Independent Companies Wilmington, DE and Midland, MI, July 20, 2016 ? DuPont (NYSE:DD) and The Dow Chemical Company (NYSE:DOW) announced that, at their respective special meetings of stockholders held today, stockholders of both companies h

Financial Statements and Exhibits, Other Events, Submission of Matters to a Vote of Security Holders

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of Earliest Event Reported): July 20, 2016 E. I. du Pont de Nemours and Company (Exact Name of Registrant as Specified in Its Charter) Delaware 1-815 51-0014090 (State or Other Jurisdiction (Commission (I.R.S. Em

Regulation FD Disclosure, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of Earliest Event Reported): July 15, 2016 (July 13, 2016) E. I. du Pont de Nemours and Company (Exact Name of Registrant as Specified in Its Charter) Delaware 1-815 51-0014090 (State or Other Jurisdiction (Commi

2

Exhibit 99.1 July 13, 2016 BY E-MAIL The Dow Chemical Company E.I. du Pont de Nemours and Company 2030 Dow Center 974 Centre Road Midland, Michigan 48674 Wilmington, Delaware 19805 Attn: Board of Directors Attn: Board of Directors Re: DowDuPont Merger Proxy To the Boards of Directors of The Dow Chemical Company and E. I. du Pont de Nemours and Company: I write on behalf of Keep Your Promises DuPon

Du Pont (E.I.) De Nemours 425 (Prospectus)

Filed by E. I. du Pont de Nemours and Company Pursuant to Rule 425 under the Securities Act of 1933, as amended, and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934, as amended Subject Company: The Dow Chemical Company; E. I. du Pont de Nemours and Company; DowDuPont Inc. Commission File No.: 001- 00815 The material below was posted to a website for U.S. Retirees of

Du Pont (E.I.) De Nemours 425 (Prospectus)

Filed by E. I. du Pont de Nemours and Company Pursuant to Rule 425 under the Securities Act of 1933, as amended, and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934, as amended Subject Company: The Dow Chemical Company; E. I. du Pont de Nemours and Company; DowDuPont Inc. Commission File No.: 001- 00815 DuPont and Dow Intended Merger of Equals Core Message Board, Jul

Du Pont (E.I.) De Nemours 425 (Prospectus)

Filed by E. I. du Pont de Nemours and Company Pursuant to Rule 425 under the Securities Act of 1933, as amended, and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934, as amended Subject Company: The Dow Chemical Company; E. I. du Pont de Nemours and Company; DowDuPont Inc. Commission File No.: 001- 00815 News To Use July 2016 DuPont and Dow Merger of Equals PROPOSED M

Regulation FD Disclosure

Document UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of Earliest Event Reported): July 8, 2016 E. I. du Pont de Nemours and Company (Exact Name of Registrant as Specified in Its Charter) Delaware 1-815 51-0014090 (State or Other Jurisdiction (Commission (I

Du Pont (E.I.) De Nemours 425 (Prospectus)

Filed by E. I. du Pont de Nemours and Company Pursuant to Rule 425 under the Securities Act of 1933, as amended, and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934, as amended Subject Company: The Dow Chemical Company; E. I. du Pont de Nemours and Company; DowDuPont Inc. Commission File No.: 001- 00815 The material below was posted to Inside the Oval, an internal we

Du Pont (E.I.) De Nemours 425 (Prospectus)

Filed by E. I. du Pont de Nemours and Company Pursuant to Rule 425 under the Securities Act of 1933, as amended, and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934, as amended Subject Company: The Dow Chemical Company; E. I. du Pont de Nemours and Company; DowDuPont Inc. Commission File No.: 001- 00815 Your Board of Directors Seeks Your Support: VOTE FOR THE DOWDUPO

Du Pont (E.I.) De Nemours 425 (Prospectus)

Filed by E. I. du Pont de Nemours and Company Pursuant to Rule 425 under the Securities Act of 1933, as amended, and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934, as amended Subject Company: The Dow Chemical Company; E. I. du Pont de Nemours and Company; DowDuPont Inc. Commission File No.: 001- 00815 DowDuPont Merger of Equals Update 1 SEC Disclosure Rules Regulat

Du Pont (E.I.) De Nemours 11-K

Document Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 11-K (Mark One) x ANNUAL REPORT PURSUANT TO SECTION 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2015 OR o TRANSITION REPORT PURSUANT TO SECTION 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number 1-815 DUPONT RETIREMENT SAVINGS PLAN (Full title of plan) E.

Du Pont (E.I.) De Nemours 11-K

Document Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 11-K (Mark One) x ANNUAL REPORT PURSUANT TO SECTION 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2015 OR o TRANSITION REPORT PURSUANT TO SECTION 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number 1-815 DUPONT 401(k) AND PROFIT SHARING PLAN (Full title of plan) E.

Du Pont (E.I.) De Nemours PRESS RELEASE (Prospectus)

Filed by E. I. du Pont de Nemours and Company Pursuant to Rule 425 under the Securities Act of 1933, as amended, and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934, as amended Subject Company: The Dow Chemical Company; E. I. du Pont de Nemours and Company; DowDuPont Inc. Commission File No.: 001- 00815 Dow and DuPont Announce DowDuPont Inc. Form S-4 Registration Sta

Du Pont (E.I.) De Nemours DEFM14A

DEFM14A Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.

Du Pont (E.I.) De Nemours ALL COLLEAGUE MEMO (Prospectus)

Filed by E. I. du Pont de Nemours and Company Pursuant to Rule 425 under the Securities Act of 1933, as amended, and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934, as amended Subject Company: The Dow Chemical Company; E. I. du Pont de Nemours and Company; DowDuPont Inc. Commission File No.: 001- 00815 EFFECTIVE S-4 ALL-COLLEAGUE MEMO FROM ED BREEN DuPont Colleagues

Du Pont (E.I.) De Nemours 425 (Prospectus)

Filed by E. I. du Pont de Nemours and Company Pursuant to Rule 425 under the Securities Act of 1933, as amended, and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934, as amended Subject Company: The Dow Chemical Company; E. I. du Pont de Nemours and Company; DowDuPont Inc. Commission File No.: 001- 00815 Dear Fellow Stockholder, On July 20, 2016, at a Special Meeting

Du Pont (E.I.) De Nemours 425 (Prospectus)

Filed by E. I. du Pont de Nemours and Company Pursuant to Rule 425 under the Securities Act of 1933, as amended, and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934, as amended Subject Company: The Dow Chemical Company; E. I. du Pont de Nemours and Company; DowDuPont Inc. Commission File No.: 001- 00815 Voting Information YOUR VOTE IS VERY IMPORTANT Each of DuPont?s

Du Pont (E.I.) De Nemours ITO Q&A (Prospectus)

Filed by E. I. du Pont de Nemours and Company Pursuant to Rule 425 under the Securities Act of 1933, as amended, and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934, as amended Subject Company: The Dow Chemical Company; E. I. du Pont de Nemours and Company; DowDuPont Inc. Commission File No.: 001- 00815 EFFECTIVE S-4 INSIDE THE OVAL Q&A DowDuPont merger plan document

Du Pont (E.I.) De Nemours LEADER TALKING POINTS (Prospectus)

Filed by E. I. du Pont de Nemours and Company Pursuant to Rule 425 under the Securities Act of 1933, as amended, and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934, as amended Subject Company: The Dow Chemical Company; E. I. du Pont de Nemours and Company; DowDuPont Inc. Commission File No.: 001- 00815 TALKING POINTS FOR USE BY LEADERS ? GUIDANCE FOR INTERACTIONS WI

CONFLICT MINERALS REPORT E. I. DU PONT DE NEMOURS AND COMPANY For the reporting period from January 1, 2015 to December 31, 2015

Exhibit Exhibit 1.01 CONFLICT MINERALS REPORT E. I. DU PONT DE NEMOURS AND COMPANY For the reporting period from January 1, 2015 to December 31, 2015 This Conflict Minerals Report (the ?Report?) of E. I. du Pont de Nemours and Company, (?DuPont? or the ?Company?) has been prepared pursuant to Rule 13p-1 and Form SD (the ?Rule?) promulgated under the Securities and Exchange Act of 1934, as amended,

Du Pont (E.I.) De Nemours SD

Document UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM SD Specialized Disclosure Report E. I. du Pont de Nemours and Company (Exact Name of Registrant as Specified in Its Charter) Delaware 1-815 51-0014090 (State or Other Jurisdiction (Commission (I.R.S. Employer Of Incorporation) File Number) Identification No.) 974 Centre Road Wilmington, Delaware 19805 (Address of

Du Pont (E.I.) De Nemours 425 (Prospectus)

Filed by E. I. du Pont de Nemours and Company Pursuant to Rule 425 under the Securities Act of 1933, as amended, and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934, as amended Subject Company: The Dow Chemical Company; E. I. du Pont de Nemours and Company; DowDuPont Inc. Commission File No.: 001- 00815 The following materials were included in materials provided by E

Du Pont (E.I.) De Nemours 425 (Prospectus)

Filed by E. I. du Pont de Nemours and Company Pursuant to Rule 425 under the Securities Act of 1933, as amended, and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934, as amended Subject Company: The Dow Chemical Company; E. I. du Pont de Nemours and Company; DowDuPont Inc. Commission File No.: 001- 00815 FACTSHEET: Update on DuPont?s Pension and Retirement Plan DuPont

Du Pont (E.I.) De Nemours 425 (Prospectus)

Filed by E. I. du Pont de Nemours and Company Pursuant to Rule 425 under the Securities Act of 1933, as amended, and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934, as amended Subject Company: The Dow Chemical Company; E. I. du Pont de Nemours and Company; DowDuPont Inc. Commission File No.: 001- 00815 TALKING POINTS FOR USE BY LEADERS ? GUIDANCE FOR INTERACTIONS WI

Du Pont (E.I.) De Nemours 425 (Prospectus)

425 1 a16-97057425.htm 425 Filed by E. I. du Pont de Nemours and Company Pursuant to Rule 425 under the Securities Act of 1933, as amended, and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934, as amended Subject Company: The Dow Chemical Company; E. I. du Pont de Nemours and Company; DowDuPont Inc. Commission File No.: 001- 00815 Dow and DuPont Announce Senior Leader

Du Pont (E.I.) De Nemours 425 (Prospectus)

Filed by E. I. du Pont de Nemours and Company Pursuant to Rule 425 under the Securities Act of 1933, as amended, and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934, as amended Subject Company: The Dow Chemical Company; E. I. du Pont de Nemours and Company; DowDuPont Inc. Commission File No.: 001- 00815 DuPont Colleagues, Today we announced key members of the future

Du Pont (E.I.) De Nemours 425 (Prospectus)

Filed by E. I. du Pont de Nemours and Company Pursuant to Rule 425 under the Securities Act of 1933, as amended, and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934, as amended Subject Company: The Dow Chemical Company; E. I. du Pont de Nemours and Company; DowDuPont Inc. Commission File No.: 001- 00815 The link below is featured on Inside the Oval, an internal emplo

Du Pont (E.I.) De Nemours 425 (Prospectus)

425 1 a16-97054425.htm 425 Filed by E. I. du Pont de Nemours and Company Pursuant to Rule 425 under the Securities Act of 1933, as amended, and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934, as amended Subject Company: The Dow Chemical Company; E. I. du Pont de Nemours and Company; DowDuPont Inc. Commission File No.: 001- 00815 CEO TOWN HALL INSIDE THE OVAL ARTICLE

Du Pont (E.I.) De Nemours 425 (Prospectus)

Filed by E. I. du Pont de Nemours and Company Pursuant to Rule 425 under the Securities Act of 1933, as amended, and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934, as amended Subject Company: The Dow Chemical Company; E. I. du Pont de Nemours and Company; DowDuPont Inc. Commission File No.: 001- 00815 Home About the Transaction For Shareholders News Contact FOR SHA

Du Pont (E.I.) De Nemours 8-K (Current Report/Significant Event)

8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of Earliest Event Reported): April 28, 2016 (April 27, 2016) E. I. du Pont de Nemours and Company (Exact Name of Registrant as Specified in Its Charter) Delaware 1-815 51-0014090 (State or Other Jurisdiction

Du Pont (E.I.) De Nemours 425 (Prospectus)

Filed by E. I. du Pont de Nemours and Company Pursuant to Rule 425 under the Securities Act of 1933, as amended, and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934, as amended Subject Company: The Dow Chemical Company; E. I. du Pont de Nemours and Company; DowDuPont Inc. Commission File No.: 001- 00815 Ceo town Hall Ed Breen, Chair & CEO april 28, 2016 CONFIDENTIAL

Du Pont (E.I.) De Nemours 425 (Prospectus)

Filed by E. I. du Pont de Nemours and Company Pursuant to Rule 425 under the Securities Act of 1933, as amended, and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934, as amended Subject Company: The Dow Chemical Company; E. I. du Pont de Nemours and Company; DowDuPont Inc. Commission File No.: 001- 00815 CONFIDENTIAL - FOR INTERNAL USE ONLY DowDuPont: Our Journey To T

Conference Call DuPont First Quarter 2016 Earnings April 26, 2016 1 Regulation G The attached charts include company information that does not conform to generally accepted accounting principles (GAAP). Management believes that an analysis of this da

dupont1q16slidesfinal Conference Call DuPont First Quarter 2016 Earnings April 26, 2016 1 Regulation G The attached charts include company information that does not conform to generally accepted accounting principles (GAAP).

Du Pont (E.I.) De Nemours 8-K (Current Report/Significant Event)

8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of Earliest Event Reported): April 26, 2016 (April 25, 2016) E. I. du Pont de Nemours and Company (Exact Name of Registrant as Specified in Its Charter) Delaware 1-815 51-0014090 (State or Other Jurisdiction